Literature DB >> 8940124

The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells.

R Salgia1, S Avraham, E Pisick, J L Li, S Raja, E A Greenfield, M Sattler, H Avraham, J D Griffin.   

Abstract

Related adhesion focal tyrosine kinase (RAFTK), also known as proline-rich tyrosine kinase 2 and cellular adhesion kinase beta, has been recently cloned and characterized as a member of the focal adhesion kinase (FAK) subfamily. RAFTK has an overall 48% amino acid homology to p125(FAK) and contains a kinase domain but lacks a transmembrane region, myristylation sites, and Src homology region 2 and 3 domains. By Northern blot analysis, RAFTK is expressed in myeloid, lymphoid, and megakaryocytic hematopoietic cells. Like p125(FAK), we found that RAFTK interacts with the focal adhesion protein paxillin. In the lymphoid cell line BaF3 and the myeloid cell line 32Dcl3, RAFTK coprecipitates with paxillin. Using in vitro binding assays, RAFTK and paxillin were shown to bind directly, through a segment of paxillin that required amino acids 100-227 and a domain in the C terminus of RAFTK. In vitro, RAFTK could phosphorylate paxillin on tyrosine residues. These results suggest that RAFTK, as well as p125(FAK), may be important in phosphotyrosine-signaling events within the focal adhesion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940124     DOI: 10.1074/jbc.271.49.31222

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF.

Authors:  M Fuortes; M Melchior; H Han; G J Lyon; C Nathan
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  β2 integrin induces TCRζ-Syk-phospholipase C-γ phosphorylation and paxillin-dependent granule polarization in human NK cells.

Authors:  Michael E March; Eric O Long
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

3.  Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration.

Authors:  M Okigaki; C Davis; M Falasca; S Harroch; D P Felsenfeld; M P Sheetz; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

4.  BCR/ABL induces multiple abnormalities of cytoskeletal function.

Authors:  R Salgia; J L Li; D S Ewaniuk; W Pear; E Pisick; S A Burky; T Ernst; M Sattler; L B Chen; J D Griffin
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  Activation of protein tyrosine kinase PYK2 by the m1 muscarinic acetylcholine receptor.

Authors:  J S Felsch; T G Cachero; E G Peralta
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

6.  Roles of paxillin phosphorylation in IL-3 withdrawal-induced Ba/F3 cell apoptosis.

Authors:  Ae Sun Nah; Kee Oh Chay
Journal:  Genes Genomics       Date:  2019-01-02       Impact factor: 1.839

7.  Hic-5-reduced cell spreading on fibronectin: competitive effects between paxillin and Hic-5 through interaction with focal adhesion kinase.

Authors:  N Nishiya; K Tachibana; M Shibanuma; J I Mashimo; K Nose
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

8.  Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells.

Authors:  R K Ganju; N Munshi; B C Nair; Z Y Liu; P Gill; J E Groopman
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Pyk2 mediates increased adrenergic contractile responses in arteries from DOCA-salt mice - VASOACTIVE PEPTIDE SYMPOSIUM.

Authors:  Fernanda R C Giachini; Fernando S Carneiro; Victor V Lima; Zidonia N Carneiro; Maria Helena C Carvalho; Zuleica B Fortes; R Clinton Webb; Rita C Tostes
Journal:  J Am Soc Hypertens       Date:  2008 Nov-Dec

10.  Structural and mechanistic insights into the interaction between Pyk2 and paxillin LD motifs.

Authors:  Murugendra S Vanarotti; Darcie J Miller; Cristina D Guibao; Amanda Nourse; Jie J Zheng
Journal:  J Mol Biol       Date:  2014-08-29       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.